23andMe Is Under Fire. Its Founder Remains ‘Optimistic’
[ad_1] You had an exclusive partnership with GlaxoSmithKline for five years, from 2018 to 2023. How successful was that? It was overwhelmingly productive. Fifty drug targets came out of it,…
[ad_1] You had an exclusive partnership with GlaxoSmithKline for five years, from 2018 to 2023. How successful was that? It was overwhelmingly productive. Fifty drug targets came out of it,…